Many diseases have known genetic medicine treatments, but lack a delivery vehicle that can bring those systems to the affected tissues and cells
Today's viral and non-viral delivery vehicles haven't solved this
AAVs and LNPs are inefficient, unsafe, low capacity, and can't target tissues that aren't the liver:
Because of their limitations, these treatments are mostly limited to rare disease and are the most expensive therapies ever made. A better approach is needed.
STAR Vectors: Solving Gene Delivery
We are developing novel Synthetic Targeted (STAR) Vectors for systemic delivery with High Tissue Tropism, Low Immunogenicity, Larger Payloads, and No Liver Sink
STAR Vectors:
Precise targeting without compromising manufacturability
Highly modular, rapid development of different targets and payloads
This enables us to treat millions of patients who have prevalent and untreatable diseases across numerous therapeutic areas
Lilium Therapeutics
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.